SCHEMBL11422147

SCHEMBL11422147

CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 9/20 0.87
▸ LMNA P02545 8/20 0.87
▸ CYP3A4 P08684 6/20 0.87
▸ NR3C1 P04150 5/20 0.87
▸ PGR P06401 4/20 0.87
▸ CNR1 P21554 2/20 0.87
▸ NPSR1 Q6W5P4 2/20 0.87
▸ MAPT P10636 2/20 0.87
▸ KCNH2 Q12809 1/20 0.87
▸ USP2 O75604 1/20 0.87
▸ NR1I2 O75469 1/20 0.81
▸ ALDH1A1 P00352 2/20 0.75
▸ AR P10275 2/20 0.75
▸ MEN1 O00255 1/20 0.75
▸ KMT2A Q03164 1/20 0.75
▸ CYP2C9 P11712 1/20 0.69
▸ TBXA2R P21731 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ HSD17B10 Q99714 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14884636 1.00 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL124165 1.00 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL28971361 1.00 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL15975096 1.00 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL1973547 0.94 HIF1A (0.81) HIF1ALMNACYP3A4NR3C1PGR
Amcinonide SCHEMBL13026154 0.93 HIF1A (1.00) HIF1ALMNACYP3A4NR3C1PGR
Amcinonide SCHEMBL5488922 0.93 HIF1A (1.00) HIF1ALMNACYP3A4NR3C1PGR
Amcinonide SCHEMBL4720 0.93 HIF1A (1.00) HIF1ALMNACYP3A4NR3C1PGR
Amcinonide SCHEMBL21051752 0.93 HIF1A (1.00) HIF1ALMNACYP3A4NR3C1PGR
Amcinonide SCHEMBL1649481 0.93 HIF1A (1.00) HIF1ALMNACYP3A4NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10233210-B2 Process for preparation of glucocorticoid steroids CORAL DRUGS PVT. LTD. (IN) 2019-03-19 — — US disclosed
US-4201778-A 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates SCHERING CORPORATION (US) 1980-05-06 — — US disclosed
US-3931167-A Process for the manufacture of 3-keto-6-azido-4,6-bis-dehydro-steroids and intermediates useful therein SCHERING CORPORATION (US) 1976-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10233210-B2 Process for preparation of glucocorticoid steroids CYP21A2, NR3C2, NR3C1 HIF1A 2505/4885LMNA 2564/4885CYP3A4 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback